BRITNEY SCOLIERI: Open Payments
NPI 1942685110 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$45,718 in 149 payments from 13 companies in 2025. Trend: 2023 $40,174 · 2024 $45,478 · 2025 $45,718
Speaker / faculty: $40,675Travel & lodging: $2,769Food & beverage: $2,274
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 100 | $44,715 |
| Otsuka America Pharmaceutical, Inc. | 11 | $271 |
| Alkermes, Inc. | 9 | $146 |
| Lundbeck LLC | 6 | $120 |
| Neurocrine BioSciences, Inc. | 4 | $82 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $78 |
| Axsome Therapeutics, Inc. | 3 | $68 |
| Corium, LLC | 2 | $53 |
| Janssen Pharmaceuticals, Inc | 3 | $44 |
| Collegium Pharmaceutical, Inc. | 2 | $38 |
Products named: VRAYLAR, REXULTI, LYBALVI, INGREZZA, CAPLYTA, Auvelity, Azstarys, Jornay PM.
Industry payments across PA — which companies pay providers there.
